Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Dorothy Fink halts reports from health agencies like the CDC, FDA and National Institutes of Health on Tuesday, The H5 bird flu is widespread in wild birds and is causing outbreaks in poultry and ...

GSK said at an R&D update in the summer that it expects to have two mRNA candidates in clinical trials within 12 months and six within the next four years, including seasonal flu shots.

GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 flu season. This immediately follows ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

The new agreement comes at a time when GSK and CureVac have been at risk of falling behind in mRNA vaccines for respiratory diseases, with combined flu/COVID-19 candidates from Moderna and Pfizer ...

Then the JP Morgan 43rd Annual Healthcare Conference featured M&A news from the likes of Johnson & Johnson (JNJ) and Europe’s GSK (GSK). 3 After a business update, shares of Eli Lilly (LLY) endured ...

GlaxoSmithKline Pharmaceuticals Limited is ... In September 2020, the Company launched tetravalent influenza flu vaccine, Fluarix Tetra to help combat influenza.In June, 2021 Company launched ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...